Patent · US Active

Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors

US7994337B2 · kind B2 · utility

0Cited by

16References

13Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Chunjian Liu · Pennington, US
Katerina Leftheris · Skillman, US
James Lin · Lawrenceville, US

Key dates

Filing date	Dec 12, 2008
Grant date	Aug 9, 2011
Priority date	—
Expiry date	Jul 14, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound of Formula (I)an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from:further wherein R1, R2, R3, R4, R5, R6, R7, and W are as described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.